Cargando…

Estrogen receptors are linked to angiotensin-converting enzyme 2 (ACE2), ADAM metallopeptidase domain 17 (ADAM-17), and transmembrane protease serine 2 (TMPRSS2) expression in the human atrium: insights into COVID-19

Detalles Bibliográficos
Autores principales:	Wang, Hao, Sun, Xuming, L. VonCannon, Jessica, Kon, Neal D., Ferrario, Carlos M., Groban, Leanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856449/ https://www.ncbi.nlm.nih.gov/pubmed/33536584 http://dx.doi.org/10.1038/s41440-021-00626-0

Ejemplares similares

ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
por: Zipeto, Donato, et al.
Publicado: (2020)

Effect of 17β-estradiol on the daily pattern of ACE2, ADAM17, TMPRSS2 and estradiol receptor transcription in the lungs and colon of male rats
por: Herichová, Iveta, et al.
Publicado: (2022)

The collectrin‐like part of the SARS‐CoV‐1 and ‐2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17
por: Niehues, Rabea Victoria, et al.
Publicado: (2022)

ADAM Metallopeptidase Domain 33 (ADAM33): A Promising Target for Asthma
por: Tripathi, Priya, et al.
Publicado: (2014)

ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation
por: Cheng, Jing, et al.
Publicado: (2022)

Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID‐19 disease
por: Khoury, Emad E., et al.
Publicado: (2021)

Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
por: Pérez-Vizcaíno, Francisco
Publicado: (2020)

A model for COVID-19-induced dysregulation of ACE2 shedding by ADAM17
por: Healy, Eamonn F., et al.
Publicado: (2021)

ADAM 17 endopeptidase
Publicado: (2009)

ADAM10 and ADAM17: New Players in Trastuzumab Resistance
por: Duffy, Michael J., et al.
Publicado: (2014)

ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis
por: Van Meenen, Dario, et al.
Publicado: (2022)

Activation of Kinin B1R Upregulates ADAM17 and Results in ACE2 Shedding in Neurons
por: Parekh, Rohan Umesh, et al.
Publicado: (2020)

Role of ADAM10 and ADAM17 in Regulating CD137 Function
por: Seidel, Jana, et al.
Publicado: (2021)

Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice
por: Pedersen, Kim Brint, et al.
Publicado: (2015)

LRP1 shedding in human brain: roles of ADAM10 and ADAM17
por: Liu, Qiang, et al.
Publicado: (2009)

Upregulation of APP, ADAM10 and ADAM17 in the Denervated Mouse Dentate Gyrus
por: Del Turco, Domenico, et al.
Publicado: (2014)

Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function
por: Leitzke, Sinje, et al.
Publicado: (2022)

Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris
por: Kugelmann, Daniela, et al.
Publicado: (2022)

Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes
por: Matthews, Jennifer, et al.
Publicado: (2021)

TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer
por: Gaweł‐Bęben, Katarzyna, et al.
Publicado: (2017)

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
por: Matthews, Alexandra L., et al.
Publicado: (2017)

Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2)
por: Fan, Lei, et al.
Publicado: (2021)

Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19
por: Posadas-Sánchez, Rosalinda, et al.
Publicado: (2022)

How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17
por: Healy, Eamonn F.
Publicado: (2022)

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
por: Sahin, Umut, et al.
Publicado: (2004)

Differential Surface Expression of ADAM10 and ADAM17 on Human T Lymphocytes and Tumor Cells
por: Ebsen, Henriette, et al.
Publicado: (2013)

The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
por: Oh, S.-T., et al.
Publicado: (2016)

ADAM10 and ADAM17 as Biomarkers Linked to Inflammation, Metabolic Disorders and Colorectal Cancer
por: Sikora-Skrabaka, Magdalena, et al.
Publicado: (2022)

ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?
por: Maas, Sanne L., et al.
Publicado: (2023)

Exploring the Potential Role of ADAM 17 and ADAM 22 in the Etiology of Autism Spectrum Disorders
por: Al-Mazidi, Sarah H., et al.
Publicado: (2023)

Mechanisms by which angiotensin-receptor blockers increase ACE2 levels
por: Ferrario, Carlos M., et al.
Publicado: (2020)

Epidermal ADAM17 is dispensable for Notch activation
por: Groot, Arjan J., et al.
Publicado: (2013)

miR-145 Alleviates Smooth Muscle Cell Phenotype Transition via ADAM17-Mediated ACE2 Shedding
por: Wen, Juan, et al.
Publicado: (2023)

ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion
por: Jocher, Georg, et al.
Publicado: (2022)

Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2021)

Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells
por: Siney, Elodie J., et al.
Publicado: (2016)

Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17
por: Alabi, Rolake O., et al.
Publicado: (2021)

Assessment of ADAM17 and ADAM10 proteins with CXCL10 and thyroid autoimmunity in vitiligo pathogenesis
por: Kılıc, Sevilay, et al.
Publicado: (2022)

ADAM10 mediates shedding of carbonic anhydrase IX ectodomain non-redundantly to ADAM17
por: Zatovicova, Miriam, et al.
Publicado: (2022)

Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells
por: Babendreyer, Aaron, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_moc7obi5njlh95i6c5kkv0tttd